Anti-inflammatory meds may increase osteoporosis risk

Individuals who take glucocorticoid medications may benefit from taking steps to support their bone health and avoid developing osteoporosis, according to a new statement from the International Osteoporosis Foundation.

Glucocorticoid medications are used to treat a wide range of inflammatory conditions, including rheumatoid arthritis, inflammatory bowel disorder and asthma. The new report states that evidence has linked these medications to high rates of bone loss, which can develop into osteoporosis if left unchecked.

The authors of the statement advised individuals who must take glucocorticoids to take preventive measures to support their bone health. This may include eating a diet rich in calcium, engaging in weight-bearing exercise and getting limited amounts of sun exposure to ensure adequate vitamin D levels.

Given the fact that bone loss can occur during the first three to six months of glucocorticoid treatment, the authors said that people taking these medications need to start taking preventive steps right away.

"Patients who are taking prednisolone, cortisone or other glucocorticoids for three months or longer, should be advised to take appropriate measures to help reduce the accompanying bone loss," said Cyrus Cooper, chair of the Foundation's Committee of Scientific Advisors.

Those who do not may be significantly more likely to develop osteoporosis, which could force them take a prescription to buy Fosamax.